Infant Bacterial Therapeutics AB logo

IBT B - Infant Bacterial Therapeutics AB News Story

SEK104.6 4.2  4.2%

Last Trade - 16/04/21

Sector
Healthcare
Size
Small Cap
Market Cap £100.7m
Enterprise Value £64.4m
Revenue £n/a
Position in Universe 905th / 1831

BRIEF-Infant Bacterial Therapeutics Announces New Patent Protection Is Granted In Japan

Tue 9th February, 2021 7:03pm
Feb 9 (Reuters) - Infant Bacterial Therapeutics AB
 IBTb.ST :
    * REG-INFANT BACTERIAL THERAPEUTICS TODAY ANNOUNCES THAT NEW
PATENT PROTECTION IS GRANTED IN JAPAN
    * JAPANESE PATENT EXPIRES IN 2036
    * PRODUCT COVERED BY PATENT IS INTENDED TO BE MARKETED IN
JAPAN
AFTER FUTURE MARKETING AUTHORIZATION
    * IBT - IS CURRENTLY DEVELOPING ITS DRUG CANDIDATE IBP-9414
IN
PHASE III FOR PREVENTION OF NEC AND IMPROVEMENT OF FEEDING
TOLERANCE IN PRETERM INFANTS

Source text for Eikon:  ID:nGNE9KmJll 
Further company coverage:  IBTb.ST 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.